According to The Cancer Genome Atlas (TCGA), 444 missense and 63 truncating mutations have been reported in the exons of SIGLEC12 in 67,030 individuals with cancer (somatic mutation frequency of 0.7%). The gene discussed is SIGLEC12; the disease is cancer.